Northwest Biotherapeutics: From An Ugly Duckling Bulletin Board Company To A Promising Nasdaq Listing
By Smith On Stocks
: Investment Update In my July 2012 report , I recommended purchase of Northwest Biotherapeutics ( NWBO ). I felt that the company represented an asymmetric investment opportunity for investors willing to risk losing much or even all of their investment for a chance to realize ...
Read the rest of this article on Healthcare Sector and Stocks Analysis from Seeking Alpha